A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer.
暂无分享,去创建一个
C. Runowicz | S. Wadler | H. Hochster | J. Holland | J. Speyer | J. Mandeli | G. Berk | R. Wallach